This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazzarotto, T.
Right arrow Articles by Landini, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazzarotto, T.
Right arrow Articles by Landini, M. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 1998, p. 3337-3341, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Development of a New Cytomegalovirus (CMV) Immunoglobulin M (IgM) Immunoblot for Detection of CMV-Specific IgM

T. Lazzarotto,1 A. Ripalti,1 G. Bergamini,1 M. C. Battista,1 P. Spezzacatena,1 F. Campanini,1 P. Pradelli,1 S. Varani,1 L. Gabrielli,1 G. T. Maine,2 and M. P. Landini1,*

Department of Clinical and Experimental Medicine, Section of Microbiology, University of Bologna, Bologna, Italy,1 and Abbott Laboratories, Abbott Park, Illinois2

Received 13 April 1998/Returned for modification 22 June 1998/Accepted 19 August 1998

We developed a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot to detect CMV-specific IgM in human sera. The new test contains four viral proteins (vp150, vp82, vp65, and vp28) purified from viral particles and four recombinant proteins (rp150, rp130, rp52, and rp38) purified from Escherichia coli. These antigens were individually loaded onto nitrocellulose strips, and the strips were then used to detect CMV-specific IgM by using a µ-specific conjugate. The new assay was evaluated in parallel with one or two IgM enzyme-linked immunosorbent assays (ELISAs) to test 592 serum samples from different groups of latently or acutely infected individuals. The sensitivity of the new assay with respect to the consensus of two ELISAs was 100%, the specificity was 98.6%, the positive predictive value was 96.9%, and the negative predictive value was 100%. We also evaluated the new test by testing sera from pregnant women and transplant recipients with a known clinical history. Our results suggest that the new test combines high sensitivity with high specificity, characteristics that are mutually exclusive with the other commercially available tests. Furthermore, a statistically significant correlation was observed between the number of IgM-reactive bands and the elevated risk of transmission from CMV-infected pregnant women to their offspring.

* Corresponding author. Mailing address: Dipartimento di Medicina Clinica Specialistica e Sperimentale, Sezione di Microbiologia, Policlinico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy. Phone: 39.051.341652. Fax: 39.051.341632. E-mail: viroland{at}med.unibo.it.

Journal of Clinical Microbiology, November 1998, p. 3337-3341, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Revello, M. G., Gerna, G. (2002). Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant. Clin. Microbiol. Rev. 15: 680-715 [Abstract] [Full Text]  
  • Lang, D., Vornhagen, R., Rothe, M., Hinderer, W., Sonneborn, H.-H., Plachter, B. (2001). Cross-Reactivity of Epstein-Barr Virus-Specific Immunoglobulin M Antibodies with Cytomegalovirus Antigens Containing Glycine Homopolymers. CVI 8: 747-756 [Abstract] [Full Text]  
  • Lazzarotto, T., Varani, S., Gabrielli, L., Pignatelli, S., Landini, M. P. (2001). The tegument protein ppUL25 of human cytomegalovirus (CMV) is a major target antigen for the anti-CMV antibody response. J. Gen. Virol. 82: 335-338 [Abstract] [Full Text]  
  • Lazzarotto, T., Galli, C., Pulvirenti, R., Rescaldani, R., Vezzo, R., La Gioia, A., Martinelli, C., La Rocca, S., Agresti, G., Grillner, L., Nordin, M., van Ranst, M., Combs, B., Maine, G. T., Landini, M. P. (2001). Evaluation of the Abbott AxSYM Cytomegalovirus (CMV) Immunoglobulin M (IgM) Assay in Conjunction with Other CMV IgM Tests and a CMV IgG Avidity Assay. CVI 8: 196-198 [Abstract] [Full Text]  
  • Nulens, E., Bodeus, M., Bonelli, F., Soleti, A., Goubau, P. (2000). Reactivity to p52 and CM2 Recombinant Proteins in Primary Human Cytomegalovirus Infection with a Microparticle Agglutination Assay. CVI 7: 536-539 [Abstract] [Full Text]  
  • Maine, G. T., Stricker, R., Schuler, M., Spesard, J., Brojanac, S., Iriarte, B., Herwig, K., Gramins, T., Combs, B., Wise, J., Simmons, H., Gram, T., Lonze, J., Ruzicki, D., Byrne, B., Clifton, J. D., Chovan, L. E., Wachta, D., Holas, C., Wang, D., Wilson, T., Tomazic-Allen, S., Clements, M. A., Wright, G. L. Jr., Lazzarotto, T., Ripalti, A., Landini, M. P. (2000). Development and Clinical Evaluation of a Recombinant-Antigen-Based Cytomegalovirus Immunoglobulin M Automated Immunoassay Using the Abbott AxSYM Analyzer. J. Clin. Microbiol. 38: 1476-1481 [Abstract] [Full Text]  
  • Eing, B. R., Baumeister, H. G., Kuehn, J. E., May, G. (1999). Long-Term Persistence of Immunoglobulin A (IgA) and IgM Antibodies against Human Cytomegalovirus in Solid-Organ Transplant Recipients. CVI 6: 621-623 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»